Log in to your Inderes Free account to see all free content on this page.
PCI Biotech Holding
Less than 1K followers
PCIB
Oslo Børs
Biotechnology & Pharmaceuticals
Health Care
Overview
Ownership
PCI Biotech Holding is a biopharmaceutical group, where most of the operations are conducted within the subsidiary PCI Biotech. The group is engaged in the development of therapeutic products based on the proprietary PCI technology. The solutions are intended for use in the treatment of cancer patients. PCI Biotech was originally founded in 2000 as a subsidiary of Photocure and is headquartered in Oslo, Norway.
Read moreMarket cap
-
Turnover
-
Revenue
EBIT %
P/E
Dividend yield-%
All
Press releases
ShowingAll content types
PCI Biotech update on future operations
PCI Biotech half-year interim 2025 report
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio